Free Content Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson's disease

Authors: Faucheux, Baptiste A.; Martin, Marie-Elise1; Beaumont, Carole1; Hauw, Jean-Jacques2; Agid, Yves3; Hirsch, Etienne C.3

Source: Journal of Neurochemistry, Volume 86, Number 5, September 2003 , pp. 1142-1148(7)

Publisher: Wiley-Blackwell

Buy & download fulltext article:

You have access to the full text article on a website external to ingentaconnect.

Please click here to view this article on Wiley Online Library.

You may be required to register and activate access on Wiley Online Library before you can obtain the full text. If you have any queries please visit Wiley Online Library

Abstract:

Degeneration of dopaminergic neurones during Parkinson's disease is most extensive in the subpopulation of melanized-neurones located in the substantia nigra pars compacta. Neuromelanin is a dark pigment produced in the dopaminergic neurones of the human substantia nigra and has the ability to bind a variety of metal ions, especially iron. Post-mortem analyses of the human brain have established that oxidative stress and iron content are enhanced in association with neuronal death. As redox-active iron (free Fe2+ form) and other transition metals have the ability to generate highly reactive hydroxyl radicals by a catalytic process, we investigated the redox activity of neuromelanin (NM)-aggregates in a group of parkinsonian patients, who presented a statistically significant reduction (− 70%) in the number of melanized-neurones and an increased non-heme (Fe3+) iron content as compared with a group of matched-control subjects. The level of redox activity detected in neuromelanin-aggregates was significantly increased (+ 69%) in parkinsonian patients and was highest in patients with the most severe neuronal loss. This change was not observed in tissue in the immediate vicinity of melanized-neurones. A possible consequence of an overloading of neuromelanin with redox-active elements is an increased contribution to oxidative stress and intraneuronal damage in patients with Parkinson's disease.

Keywords: iron; neuromelanin; Parkinson's disease; redox activity; substantia nigra

Document Type: Research article

DOI: http://dx.doi.org/10.1046/j.1471-4159.2003.01923.x

Affiliations: 1: U.409, Faculté de Médecine X. Bichat, Paris, France 2: U.360, Hôpital de la Salpêtrière 3: INSERM, U.289, and

Publication date: 2003-09-01

Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page